Woodline Partners LP

13F Holdings History for Aligos Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (ALGS)

Symbol: ALGS on Nasdaq
Investment type: Equity / Voting Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 518K shares
Security Ownership: 9.8%

Shares, Excluding Options vs Price

Value, Excluding Options

Woodline Partners LP ownership in Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS)

2025-08-14 - Woodline Partners LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 518K shares of Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS). This represents 9.8% percent ownership of the company. In their previous filing dated 2025-05-15, Woodline Partners LP had reported owning 315K shares, indicating an increase of 64.3% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Woodline Partners LP	9.8%	+92%	$3.86M	518K	+202,917	+64.3%	$7.44	13G/A	6/30/2025	14 Aug 2025 11:54:19
Woodline Partners LP	5.2%		$1.29M	315K			$4.08	13G	3/31/2025	15 May 2025 09:33:49

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.02%	+0.01%	$3.74M	518K	+202,917	+64.3%	$7.21	Q2 2025
3/31/2025	0.02%	+0.02%	$2.6M	315K	+315,383	NEW	$8.25	Q1 2025
12/31/2024		-0.01%	$0	0	-91,971	-100%		Q4 2024
9/30/2024	0.01%	+0.01%	$796K	92K	+91,971	NEW	$8.66	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.